Smith Graham & Co Investment Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-245,440
| Closed | -$5.82M | – | 146 |
|
|
2023
Q3 | $5.82M | Sell |
245,440
-380,004
| -61% | -$7.15M | 0.72% | 54 |
|
|
2023
Q2 | $10.1M | Sell |
625,444
-27,528
| -4% | -$456K | 1.23% | 11 |
|
|
2023
Q1 | $11.4M | Sell |
652,972
-2,062
| -0.3% | -$37.1K | 1.38% | 7 |
|
|
2022
Q4 | $12.3M | Sell |
655,034
-25,141
| -4% | -$484K | 1.51% | 5 |
|
|
2022
Q3 | $12M | Sell |
680,175
-961
| -0.1% | -$16.7K | 1.6% | 4 |
|
|
2022
Q2 | $11.9M | Sell |
681,136
-40,796
| -6% | -$778K | 1.47% | 5 |
|
|
2022
Q1 | $15.1M | Sell |
721,932
-4,724
| -0.7% | -$90.5K | 1.57% | 3 |
|
|
2021
Q4 | $12.9M | Sell |
726,656
-59,340
| -8% | -$953K | 1.29% | 15 |
|
|
2021
Q3 | $11.1M | Sell |
785,996
-67,819
| -8% | -$1.05M | 1.11% | 19 |
|
|
2021
Q2 | $14.2M | Sell |
853,815
-108,091
| -11% | -$1.94M | 1.25% | 15 |
|
|
2021
Q1 | $17.4M | Buy |
961,906
+61,323
| +7% | +$1.21M | 1.41% | 11 |
|
|
2020
Q4 | $16.4M | Sell |
900,583
-16,326
| -2% | -$259K | 1.51% | 7 |
|
|
2020
Q3 | $11.7M | Sell |
916,909
-13,797
| -1% | -$176K | 1.33% | 13 |
|
|
2020
Q2 | $10.2M | Buy |
930,706
+261,429
| +39% | +$2.71M | 1.24% | 17 |
|
|
2020
Q1 | $6.99M | Buy |
669,277
+139,835
| +26% | +$1.8M | 1.09% | 22 |
|
|
2019
Q4 | $8.51M | Buy |
529,442
+24,727
| +5% | +$409K | 0.83% | 45 |
|
|
2019
Q3 | $7.91M | Buy |
504,715
+3,120
| +0.6% | +$51.9K | 0.84% | 45 |
|
|
2019
Q2 | $9.98M | Buy |
501,595
+7,497
| +2% | +$140K | 1.08% | 18 |
|
|
2019
Q1 | $8.32M | Sell |
494,098
-41,510
| -8% | -$720K | 0.91% | 35 |
|
|
2018
Q4 | $8.11M | Buy |
535,608
+20,150
| +4% | +$346K | 0.99% | 23 |
|
|
2018
Q3 | $10.3M | Sell |
515,458
-38,955
| -7% | -$826K | 0.98% | 25 |
|
|
2018
Q2 | $10.8M | Sell |
554,413
-95,020
| -15% | -$1.5M | 1.02% | 21 |
|
|
2018
Q1 | $8.87M | Buy |
649,433
+81,257
| +14% | +$1.07M | 0.85% | 43 |
|
|
2017
Q4 | $7.72M | Buy |
568,176
+40,270
| +8% | +$578K | 0.73% | 61 |
|
|
2017
Q3 | $8.3M | Sell |
527,906
-5,360
| -1% | -$86.5K | 0.87% | 42 |
|
|
2017
Q2 | $9.18M | Sell |
533,266
-29,070
| -5% | -$442K | 0.99% | 27 |
|
|
2017
Q1 | $8.57M | Sell |
562,336
-10,550
| -2% | -$155K | 0.91% | 33 |
|
|
2016
Q4 | $7.53M | Buy |
572,886
+140,490
| +32% | +$1.8M | 0.82% | 52 |
|
|
2016
Q3 | $4.89M | Buy |
432,396
+12,050
| +3% | +$145K | 0.62% | 77 |
|
|
2016
Q2 | $5.01M | Buy |
420,346
+3,365
| +0.8% | +$45.3K | 0.69% | 67 |
|
|
2016
Q1 | $6.36M | Buy |
416,981
+49,830
| +14% | +$756K | 0.83% | 44 |
|
|
2015
Q4 | $5.92M | Buy |
+367,151
| New | +$5.36M | 0.84% | 47 |
|
Other funds holding NXGN
Smith Graham & Co Investment Advisors's NXGN Position: Q4 2023 in Review
Smith Graham & Co Investment Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 245,440 shares — an estimated $5.82M sold.
Smith Graham & Co Investment Advisors first reported a position in NXGN in Q4 2015 and held it in 32 quarters. The position peaked at $17.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Smith Graham & Co Investment Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Smith Graham & Co Investment Advisors sold 245,440 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $5.82M.
- Smith Graham & Co Investment Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2015 and held it in 32 quarters.
- Smith Graham & Co Investment Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $17.4M in Q1 2021.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.